Bajaj HealthCare Limited (NSE:BAJAJHCARE)
India flag India · Delayed Price · Currency is INR
485.00
-13.00 (-2.61%)
Jul 31, 2025, 3:30 PM IST

CTI BioPharma Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
Operating Revenue
5,5925,4264,7346,4586,7996,570
Upgrade
5,5925,4264,7346,4586,7996,570
Upgrade
Revenue Growth (YoY)
17.50%14.61%-26.69%-5.01%3.49%59.96%
Upgrade
Cost of Revenue
3,0152,8642,5743,8494,9954,692
Upgrade
Gross Profit
2,5772,5622,1602,6091,8041,878
Upgrade
Selling, General & Admin
587.09570.58446.19432.72412.63351.75
Upgrade
Other Operating Expenses
1,1661,167949.251,060172.21139.45
Upgrade
Operating Expenses
2,0212,0161,6721,665761.21652.44
Upgrade
Operating Income
556.07545.08488.35943.371,0431,226
Upgrade
Interest Expense
-246.86-279.04-290.53-163.99-110.01-60.76
Upgrade
Interest & Investment Income
--3.294.281.721.67
Upgrade
Currency Exchange Gain (Loss)
--18.77--19.3944.02
Upgrade
Other Non Operating Income (Expenses)
194.28194.04-6.94-10.09-17.81-22.62
Upgrade
EBT Excluding Unusual Items
503.49460.08212.93773.57897.661,188
Upgrade
Gain (Loss) on Sale of Assets
--0.360.04-0.12
Upgrade
Asset Writedown
---443.28---
Upgrade
Other Unusual Items
-----1-
Upgrade
Pretax Income
503.49460.08-166.76781.82896.851,188
Upgrade
Income Tax Expense
32.7330.79-23.49146.5182.99357.11
Upgrade
Earnings From Continuing Operations
470.76429.29-143.27635.33713.86831.09
Upgrade
Earnings From Discontinued Operations
-28.79-34.33-694.67-205.08--
Upgrade
Net Income
441.97394.96-837.93430.24713.86831.09
Upgrade
Net Income to Common
441.97394.96-837.93430.24713.86831.09
Upgrade
Net Income Growth
----39.73%-14.11%229.32%
Upgrade
Shares Outstanding (Basic)
313028282828
Upgrade
Shares Outstanding (Diluted)
313028282828
Upgrade
Shares Change (YoY)
13.64%9.08%----
Upgrade
EPS (Basic)
14.3813.29-30.3615.5925.8730.11
Upgrade
EPS (Diluted)
14.1013.12-30.3615.5925.8730.11
Upgrade
EPS Growth
----39.73%-14.09%229.28%
Upgrade
Free Cash Flow
-100.82620.08-1,158-786.19-702.3
Upgrade
Free Cash Flow Per Share
-3.3522.47-41.95-28.49-25.45
Upgrade
Dividend Per Share
-1.0001.0001.0001.5000.875
Upgrade
Dividend Growth
----33.33%71.43%-
Upgrade
Gross Margin
46.09%47.21%45.63%40.39%26.54%28.59%
Upgrade
Operating Margin
9.94%10.05%10.32%14.61%15.34%18.66%
Upgrade
Profit Margin
7.90%7.28%-17.70%6.66%10.50%12.65%
Upgrade
Free Cash Flow Margin
-1.86%13.10%-17.93%-11.56%-10.69%
Upgrade
EBITDA
826.94824.26800.761,2161,2201,387
Upgrade
EBITDA Margin
14.79%15.19%16.91%18.82%17.94%21.11%
Upgrade
D&A For EBITDA
270.87279.18312.41272.35176.37161.24
Upgrade
EBIT
556.07545.08488.35943.371,0431,226
Upgrade
EBIT Margin
9.94%10.05%10.32%14.61%15.34%18.66%
Upgrade
Effective Tax Rate
6.50%6.69%-18.74%20.40%30.05%
Upgrade
Revenue as Reported
5,7865,6204,8216,4746,8136,639
Upgrade
Advertising Expenses
--7.666.580.945.66
Upgrade
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.